Microglia

Microglia is the resident parenchymal macrophage lineage of the central nervous system, accounting for 5% to 12% of total cells across mammalian brain and spinal cord regions. First distinguished from macroglia in 1919 by Pío del Río-Hortega using silver carbonate staining, microglia differ in embryonic germ-layer origin from every neuron, astrocyte, and oligodendrocyte in the brain: rather than arising from neuroectoderm, microglia originate from primitive mesodermal hematopoiesis in the extra-embryonic yolk sac and invade the embryonic brain rudiment before closure of the cerebral vasculature. Once secluded inside brain parenchyma, microglia sustain their population throughout life via slow local self-renewal without replacement by circulating bone-marrow monocytes under healthy conditions.

Rather than resting as dormant sentinels, healthy homeostatic microglia extend motile, ramified filopodia that palpate synapses, neuronal somata, nodes of Ranvier, and capillaries, scanning the entire brain parenchyma every few hours. Through purinergic chemotaxis, classical complement opsonization, and lipid-sensing immunoreceptors, microglia sculpt developing circuits via synaptic pruning, clear cellular and myelin debris, modulate Alzheimer's disease progression, and initiate acute encapsulation around implanted neural interfaces.

Erythromyeloid Progenitor Colonization and CSF1R Maintenance

Genetic fate-mapping in 2010 by Florent Ginhoux, Miriam Merad, and colleagues using inducible Runx1 knock-in mice proved that adult parenchymal microglia descend from c-Kit⁺ erythromyeloid progenitors (EMPs) generated during primitive hematopoiesis in blood islands of the extra-embryonic yolk sac at embryonic day 7.25 to 7.5 in mice (gestational weeks 4 to 5 in humans). Unlike definitive hematopoietic stem cells, yolk-sac microglial specification is independent of MYB and instead requires myeloid transcription factors PU.1 (SPI1), IRF8, and RUNX1. Primitive macrophages colonize the neuroepithelium derived from radial glia starting at murine embryonic day 9.5—prior to endothelial tight-junction sealing of the blood-brain barrier.

Lifelong survival and proliferation depend on colony-stimulating factor 1 receptor (CSF1R) activated by CSF-1 and neuron-derived interleukin-34 (IL-34); Csf1r-null mice lack microglia, and small-molecule CSF1R inhibitors reversibly deplete >95% of adult microglia. Parenchymal TGF-β1 induces homeostatic signature markers—TMEM119, P2RY12, SALL1, CX3CR1, and HEXB—distinguishing parenchymal microglia from border-associated meningeal and perivascular macrophages.

Reconstituting Microglia in Immunocompetent Cerebral Organoids

Because standard three-dimensional cerebral organoid protocols pattern induced pluripotent stem cell aggregates toward neuroectoderm via dual-SMAD inhibition (suppressing mesoderm), conventional brain organoids develop without endogenous microglia. To engineer immunocompetent organoids, human iPSCs are differentiated separately through primitive mesoderm (BMP4, VEGF, SCF) and myeloid cytokines (IL-3, M-CSF, IL-34, TGF-β1) into induced microglia-like cells (iMGLs) and co-cultured with cortical organoids. Simon T. Schafer, Fred H. Gage, and colleagues (2023) demonstrated that xenotransplanting iMGL-populated human organoids into vascularized rodent cortex induces authentic ramified TMEM119⁺/P2RY12⁺ human homeostatic states free of dish-culture stress artifacts.

Ramified Motility and P2RY12 ATP Chemotaxis

In vivo two-photon imaging shows that homeostatic microglia maintain resting membrane potentials via THIK-1 (KCNK13) K⁺ channels while extending and retracting fine processes at 1.5 to 3.0 μm/min to sample presynaptic boutons and spines in an activity-sensitive manner. Focal cellular injury, capillary microbleeds, or activity-coupled release generates extracellular ATP hydrolyzed by ectonucleotidase CD39 into ADP, which binds the microglial G_i-coupled purinergic receptor P2RY12 to steer rapid PI3Kγ/Rac1-driven process convergence toward the lesion within minutes.

Classical Complement (C1q–C3–CR3) and TREM2 Synaptic Pruning

Landmark studies by Beth Stevens, Ben A. Barres, and colleagues (2007) in the retinogeniculate visual system and Rosa C. Paolicelli, Cornelius T. Gross, and colleagues (2011) in juvenile hippocampus established that microglia eliminate weak, asynchronous synapse connections while sparing active inputs protected by CD47–SIRPα "don't-eat-me" signaling:

1. Complement Opsonization: Less-active spines expose outer-leaflet phosphatidylserine and bind microglial C1q, cleaving complement component 4 (notably human C4A) and C3 to deposit covalent iC3b tags recognized by microglial complement receptor 3 (CR3, CD11b/CD18) for phagocytic trogocytosis; high-copy human C4A alleles drive excessive adolescent prefrontal spine pruning in schizophrenia.
2. TREM2–DAP12 Lipid Sensing: TREM2 signaling via DAP12 (TYROBP) and SYK kinase recognizes anionic phospholipids and APOE complexes to support developmental synapse refinement and phagocytic metabolism.

Alzheimer's Disease Genetics and the DAM Checkpoint

Human Alzheimer's disease genetics implicates microglial loci—including APOE (ε4), rare loss-of-function TREM2 variants (R47H, elevating risk ~3- to 4-fold), CD33, MS4A4A, INPP5D (encoding the lipid phosphatase SHIP1), ABI3, and PLCG2 (where the hypermorphic P522R coding variant confers longevity-associated protection)—as central drivers of amyloid and tau pathology. Single-cell transcriptomics by Hadas Keren-Shaul, Ido Amit, and colleagues (2017) identified plaque-clustering disease-associated microglia (DAM), which downregulate homeostatic checkpoints (P2RY12, TMEM119, CX3CR1) during a TREM2-independent Stage 1 transition and require TREM2–DAP12–SYK signaling in Stage 2 to induce APOE, LPL, CST7, CLEC7A, AXL, and ITGAX (CD11c). Stage 2 DAM form a protective phagocytic barrier around senile plaques that compacts neurotoxic soluble and protofibrillar amyloid-β oligomers into inert dense cores while clearing cholesterol esters from degenerating myelin membranes; conversely, chronic late-stage NLRP3 inflammasome activation and ASC-speck release can seed new amyloid plaques and exacerbate tau-mediated synaptic loss.

Peri-Implant Activation on Penetrating Microelectrode Arrays

When a penetrating microelectrode array is implanted into motor or sensory cortex for a brain-computer interface, severed microvessels breach the vascular basement membrane and leak extracellular ATP, albumin, and plasma fibrinogen into brain parenchyma. Within 10 to 30 minutes of insertion, two-photon microscopy reveals nearby surveillant microglia extending P2RY12-guided lamellipodia directly onto the foreign shank and binding immobilized fibrin γ-chain epitopes via CD11b/CD18 (CR3). Over the subsequent 24 to 72 hours, peri-implant microglia retract their distal branches, adopt amoeboid CD68⁺ morphologies, and compact into a surface monolayer secreting NADPH-oxidase superoxide radicals, nitric oxide, and the cytokine triad IL-1α, TNF, and C1q—converting surrounding astrocyte populations into scar-forming reactive states that raise chronic 1-kHz electrode impedance unless mitigated by subcellular flexible polymer probes.

Why do standard cerebral organoids lack endogenous microglia?

Standard cerebral organoid protocols direct pluripotent stem cells toward neuroectoderm while blocking mesodermal differentiation. Because parenchymal microglia arise from mesodermal extra-embryonic yolk-sac erythromyeloid progenitors outside the neural tube, neuroectoderm-only organoids lack microglia unless co-assembled with separately differentiated iPSC microglia-like cells (iMGLs).

How do microglia prune weak synapses while sparing active neighboring synapses?

Electrically active synapses display protective surface markers such as CD47 (engaging inhibitory microglial SIRPα) and complement regulators (CSMD1), whereas weak or asynchronous synapses expose phosphatidylserine and accumulate C1q, C4A, and iC3b opsonins that trigger selective engulfment via microglial complement receptor 3 (CR3).

Why do TREM2 loss-of-function mutations increase Alzheimer's disease risk?

Partial loss-of-function variants such as TREM2 R47H prevent microglia from completing the Stage 2 transition into lipid-clearing disease-associated microglia (DAM). Without TREM2-driven plaque compaction and cholesterol clearance, diffuse amyloid-β protofibrils spread outward and accelerate tau-dependent neuritic dystrophy.

1. Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., ... & Merad, M. (2010). Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science, 330(6005), 841–845. https://doi.org/10.1126/science.1194637
2. Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., ... & Barres, B. A. (2007). The classical complement cascade mediates CNS synapse elimination. Cell, 131(6), 1164–1178. https://doi.org/10.1016/j.cell.2007.10.036
3. Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., ... & Gross, C. T. (2011). Synaptic pruning by microglia is necessary for normal brain development. Science, 333(6048), 1456–1458. https://doi.org/10.1126/science.1202529
4. Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., ... & Amit, I. (2017). A unique microglia type associated with restricting development of Alzheimer's disease. Cell, 169(7), 1276–1290. https://doi.org/10.1016/j.cell.2017.05.018
5. Schafer, S. T., Mansour, A. A., Schlachetzki, J. C. M., Pena, M., Ghassemzadeh, S., Mitchell, L., ... & Gage, F. H. (2023). An in vivo neuroimmune organoid model to study human microglia phenotypes. Cell, 186(10), 2111–2126. https://doi.org/10.1016/j.cell.2023.04.022